Loading chat...

FL H2491

Bill

Official Source

Status

Introduced

11/1/2021

Primary Sponsor

Anthony Rodriguez

Click for details

Origin

House of Representatives

2022 Regular Session

AI Summary

  • Designates the Extended-Release Injectable Naltrexone (Vivitrol) Program as an Appropriations Project per Appropriations Project Request 294
  • Appropriates $847,408 in nonrecurring General Revenue Fund monies to the State Court System for fiscal year 2022-2023
  • Funds support the Extended-Release Injectable Naltrexone (Vivitrol) Program as detailed in Appropriations Project Request 294
  • Effective date is July 1, 2022

Legislative Description

Extended-Release Injectable Naltrexone (Vivitrol) Program

Last Action

See HB 5001 (line item 3243)

3/14/2022

Committee Referrals

Appropriations1/12/2022
Justice Appropriations Subcommittee11/9/2021

Full Bill Text

No bill text available